Bank of New York Mellon’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $549K | Sell |
211,183
-32,382
| -13% | -$84.2K | ﹤0.01% | 3442 |
|
|
2025
Q1 | $463K | Buy |
243,565
+5,590
| +2% | +$10.6K | ﹤0.01% | 3469 |
|
|
2024
Q4 | $345K | Buy |
237,975
+6,041
| +3% | +$8.76K | ﹤0.01% | 3679 |
|
|
2024
Q3 | $427K | Sell |
231,934
-52,004
| -18% | -$95.7K | ﹤0.01% | 3592 |
|
|
2024
Q2 | $284K | Buy |
283,938
+31,433
| +12% | +$31.4K | ﹤0.01% | 3830 |
|
|
2024
Q1 | $500K | Sell |
252,505
-18,659
| -7% | -$36.9K | ﹤0.01% | 3521 |
|
|
2023
Q4 | $423K | Sell |
271,164
-1,288
| -0.5% | -$2.01K | ﹤0.01% | 3642 |
|
|
2023
Q3 | $537K | Buy |
272,452
+1,156
| +0.4% | +$2.28K | ﹤0.01% | 3502 |
|
|
2023
Q2 | $863K | Buy |
271,296
+231,990
| +590% | +$738K | ﹤0.01% | 3282 |
|
|
2023
Q1 | $129K | Hold |
39,306
| – | – | ﹤0.01% | 4027 |
|
|
2022
Q4 | $198K | Buy |
39,306
+15,055
| +62% | +$75.7K | ﹤0.01% | 3973 |
|
|
2022
Q3 | $55K | Buy |
+24,251
| New | +$55K | ﹤0.01% | 4301 |
|